S'abonner

The Association of the Average Epinephrine Dosing Interval and Survival With Favorable Neurologic Status at Hospital Discharge in Out-of-Hospital Cardiac Arrest - 25/11/19

Doi : 10.1016/j.annemergmed.2019.04.031 
Brian Grunau, MD, MHSc a, c, , Takahisa Kawano, MD, PhD d, Frank X. Scheuermeyer, MD, MHSc a, c, Ian Drennan, BSc, ACP e, Christopher B. Fordyce, MD, MSc b, Sean van Diepen, MD, MSc g, Joshua Reynolds, MD, MS h, Steve Lin, MDCM, MSc f, Jim Christenson, MD a, c
a Department of Emergency Medicine, University of British Columbia, British Columbia, Canada 
b Division of Cardiology, University of British Columbia, British Columbia, Canada 
c Centre for Health Evaluation and Outcome Sciences, and St. Paul’s Hospital, Vancouver, British Columbia, Canada 
d Department of Emergency Medicine, University of Fukui Hospital, Fukui Prefecture, Japan 
e Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 
f Division of Emergency Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada 
g Department of Critical Care and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada 
h Department of Emergency Medicine, Michigan State University College of Human Medicine, Grand Rapids, MI 

Corresponding Author.

Abstract

Study objective

For patients with out-of-hospital cardiac arrest, the recommended dosing interval of epinephrine is 3 to 5 minutes, but this recommendation is based on expert opinion without data to guide optimal management. We seek to evaluate the association between the average epinephrine dosing interval and patient outcomes.

Methods

In a secondary analysis of the Resuscitation Outcomes Consortium continuous chest compression trial, we identified consecutive patients treated with greater than or equal to 2 doses of epinephrine. We defined average epinephrine dosing interval as resuscitation duration after the first dose of epinephrine divided by the total administered epinephrine, and categorized the dosing interval in minutes as less than 3, 3 to less than 4, 4 to less than 5, and greater than or equal to 5. We fit a logistic regression model to estimate the association of the average epinephrine dosing interval category with survival with favorable neurologic status (modified Rankin Scale score ≤3) at hospital discharge.

Results

We included 15,909 patients (median age 68 years [interquartile range 56 to 80 years], 35% women, 13% public location, 46% bystander cardiopulmonary resuscitation, and 19% initial shockable rhythm). The median epinephrine dosing interval was 4.3 minutes (interquartile range 3.5 to 5.3 minutes). Survival with favorable neurologic status occurred in 4.7% of patients. Compared with the reference dosing interval of less than 3 minutes, longer epinephrine dosing intervals were associated with lower survival with favorable neurologic status: dosing interval 3 to less than 4 minutes, adjusted odds ratio 0.44 (95% confidence interval 0.32 to 0.60); 4 to less than 5 minutes, adjusted odds ratio 0.26 (95% confidence interval 0.18 to 0.36); and greater than or equal to 5 minutes, adjusted odds ratio 0.21 (95% confidence interval 0.15 to 0.30).

Conclusion

In this out-of-hospital cardiac arrest series, a shorter average epinephrine dosing interval was associated with improved survival with favorable neurologic status.

Le texte complet de cet article est disponible en PDF.

Plan


 Please see page 798 for the Editor’s Capsule Summary of this article.
 Supervising editor: Henry E. Wang, MD, MS. Specific detailed information about possible conflict of interest for individual editors is available at editors.
 Author contributions: BG conceived the study. JC supervised original data collection. All authors designed the investigation. TK performed the statistical analysis. BG drafted the article, and all authors contributed substantially to its revision. BG takes responsibility for the paper as a whole.
 All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. The BC Resuscitation Research Unit is supported by the Heart and Stroke Foundation, the Institute for Circulatory and Respiratory Health of the Canadian Institutes of Health Research, the Provincial Health Services Authority, and Providence Health Care.
 Readers: click on the link to go directly to a survey in which you can provide 2MTNQ9D to Annals on this particular article.
 A podcast for this article is available at www.annemergmed.com.


© 2019  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 74 - N° 6

P. 797-806 - décembre 2019 Retour au numéro
Article précédent Article précédent
  • Intubation by Emergency Physicians: How Often Is Enough?
  • Benjamin T. Kerrey, Henry Wang
| Article suivant Article suivant
  • Epinephrine in Out-of-Hospital Cardiac Arrest: What Is the Role of the Timing Interval?
  • Nicholas M. Mohr, Brett Faine

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.